Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

NCT05266586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias
High Cholesterol
Hypercholesterolemia

Interventions

DRUG: Obicetrapib
DRUG: Ezetimibe 10mg
OTHER: Obicetrapib placebo
OTHER: Ezetimibe placebo

Sponsor

NewAmsterdam Pharma